BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16335545)

  • 1. The prevalence of genital Chlamydia trachomatis in Australia 1997-2004: a systematic review.
    Vajdic CM; Middleton M; Bowden FJ; Fairley CK; Kaldor JM
    Sex Health; 2005; 2(3):169-83. PubMed ID: 16335545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genital Chlamydia trachomatis infection in Australia: epidemiology and clinical implications.
    Chen MY; Donovan B
    Sex Health; 2004; 1(4):189-96. PubMed ID: 16335749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic.
    Magder LS; Harrison HR; Ehret JM; Anderson TS; Judson FN
    Am J Epidemiol; 1988 Aug; 128(2):298-308. PubMed ID: 3394697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denominators count: supplementing surveillance data for genital Chlamydia trachomatis infection with testing data, Norway, 2007 to 2013.
    Kløvstad H; Aavitsland P
    Euro Surveill; 2015; 20(36):. PubMed ID: 26535784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis.
    Lewis D; Newton DC; Guy RJ; Ali H; Chen MY; Fairley CK; Hocking JS
    BMC Infect Dis; 2012 May; 12():113. PubMed ID: 22583480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital Chlamydia trachomatis infection in Australia.
    Garland SM; Gertig DM; McInnes JA
    Med J Aust; 1993 Jul; 159(2):90-6. PubMed ID: 8123085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the number of genital chlamydial infections in the United States.
    Judson FN
    J Reprod Med; 1985 Mar; 30(3 Suppl):269-72. PubMed ID: 4020783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. Il Over 90% participation and almost 5% prevalence].
    van den Hoek JA; Mulder-Folkerts DK; Coutinho RA; Dukers NH; Buimer M; van Doornum GJ
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):668-72. PubMed ID: 10321299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay.
    Marrazzo JM; White CL; Krekeler B; Celum CL; Lafferty WE; Stamm WE; Handsfield HH
    Ann Intern Med; 1997 Nov; 127(9):796-803. PubMed ID: 9382400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of notified genital Chlamydia trachomatis infection in Victoria, Australia: a survey of diagnosing providers.
    Thompson SC; McEachern KA; Stevenson EM; Forsyth JR
    Int J STD AIDS; 1997 Jun; 8(6):382-7. PubMed ID: 9179649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, epidemiological and clinical correlates of genital Chlamydia trachomatis infection.
    Tchoudomirova K; Nuhov P; Tchapanova A
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):214-20. PubMed ID: 9883432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of genital chlamydial infection among a community sample of young international backpackers in Sydney, Australia.
    Davies SC; Karagiannis T; Headon V; Wiig R; Duffy J
    Int J STD AIDS; 2011 Mar; 22(3):160-4. PubMed ID: 21464454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012.
    Torrone E; Papp J; Weinstock H;
    MMWR Morb Mortal Wkly Rep; 2014 Sep; 63(38):834-8. PubMed ID: 25254560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?
    Götz H; Lindback J; Ripa T; Arneborn M; Ramsted K; Ekdahl K
    Scand J Infect Dis; 2002; 34(1):28-34. PubMed ID: 11874161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.
    Low N; McCarthy A; Macleod J; Salisbury C; Campbell R; Roberts TE; Horner P; Skidmore S; Sterne JA; Sanford E; Ibrahim F; Holloway A; Patel R; Barton PM; Robinson SM; Mills N; Graham A; Herring A; Caul EO; Davey Smith G; Hobbs FD; Ross JD; Egger M;
    Health Technol Assess; 2007 Mar; 11(8):iii-iv, ix-xii, 1-165. PubMed ID: 17311735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic home screening for Chlamydia trachomatis infections of asymptomatic men and women in family practice by means of mail-in urine samples].
    van Valkengoed IG; Boeke AJ; van den Brule AJ; Morré SA; Dekker JH; Meijer CJ; van Eijk JT
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):672-6. PubMed ID: 10321300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control.
    Klavs I; Rodrigues LC; Wellings K; Kese D; Hayes R
    Sex Transm Infect; 2004 Apr; 80(2):121-3. PubMed ID: 15054174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis infection in sexually active adolescents: prevalence and risk factors.
    Chacko MR; Lovchik JC
    Pediatrics; 1984 Jun; 73(6):836-40. PubMed ID: 6547226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population based study of genital Chlamydia trachomatis prevalence and associated factors in Norway: a cross sectional study.
    Kløvstad H; Grjibovski A; Aavitsland P
    BMC Infect Dis; 2012 Jul; 12():150. PubMed ID: 22747602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.